Launch Blue Announces Spring ‘24 UAccel Quick Start + I-Corps Cohort
Launch Blue is pleased to announce, 11 teams have been selected to participate in the 12-week Spring 2024 UAccel Quick Start + I-Corps program. This is the tenth UAccel cohort under the Launch Blue banner.
UAccel Quick Start + I-Corps offers business development and an experiential learning opportunity to innovators in higher education interested in learning the best commercialization path for their technology. The goal of the program is to advance the technology toward commercialization, including preparations for Small Business Innovation Research (SBIR) grant applications, the creation of a startup, or licensing of the technology. UAccel Quick Start is organized in partnership with the University of Kentucky Office of Technology Commercialization and Kentucky Commercialization Ventures.
UAccel Quick Start is the first phase of Launch Blue’s two-phase program for innovators in higher education, the second phase is Innovation Corps (I-Corps). The National Science Foundation’s Innovation Corps program is an immersive, entrepreneurial training program that facilitates the transformation of invention to impact. The University of Kentucky is a member of the NSF’s Mid-South I-Corps Hub and offers a regional I-Corps program through Launch Blue.
Candidates were selected through a competitive application and interview process. The final selections for the cohort were determined by a selection committee appointed by the organizing partners. Applications for the Summer 2024 UAccel Quick Start + I-Corps program will open on April 1.
This consultancy is dedicated to expediting the development of legal expertise within arts and cultural nonprofit organizations in Kentucky through research and education.
A new, large-scale effort for the recording and analysis of seismic data using a combination of novel instrumentation and artificial intelligence.
A sandwich ELISA that detects amylin-Aβ hetero-oligomers in brain tissue and blood samples of Alzheimer’s disease patients. This ELISA is helpful in assessing the effect of diabetes on Alzheimer’s disease.
D12 Scientific is focused on the development of cost-effective and user-friendly point-of-care diagnostics for communicable and non-communicable diseases.
NanoMed is an adaptive and non-invasive targeted drug delivery technology, NAT-1, for treating superficial cancers. NAT-1 enables the simultaneous delivery of dual chemotherapy agents, thereby reducing cancer drug resistance.
A Single Nucleotide Polymorphism-based, Mixed Cell Screening platform, where the reactions of each cell line toward the candidate compound treatment can be differentiated by using “genetic tags” of each cell line and subsequent proprietary statistical deconvolution algorithm.
Global Asias Research and Creativity Incubator aims to synthesize current research concerning Asia, the AAPI communities in Kentucky, the global Asian diaspora, and other underrepresented communities through international and local collaboration, and making such research accessible.
The Death Scene Investigation Mobile Technology aims to improve written scene documentation and photo evidence and documentation of decedent information.
An educational board game to review fundamental nursing concepts, making learning and reviewing key concepts fun and interactive.
A tool used during the retrieval of bone via a bone biopsy procedure by refining the cutting method used to minimize bone damage and optimize bone core sample retrieval.
A 10-minute 'anywhere workout' program hosted on an innovative digital platform, where users can engage directly with the trainer and offers a holistic experience that rejuvenates the body, mind, and soul.